āagman

Not investment advice. Data and computed figures, for information only.

Global Health Ltd

NSE: MEDANTA
₹1,275.50
−₹4.50 (−0.35%)
NSE · 15 Oct 2026, close
NSE
As of 31 Mar 2026
Market Cap
₹35,295 Cr
CMP
₹1,275.50
52-wk High / Low
₹1,544 / 956
P/E
61.6
P/B
8.9
Book Value
₹147.0
Div Yield
0.04%
ROCE
17.0%
ROE
15.2%
Face Value
₹2
D/E
0.30

Price−5.5% over 1Y

āagman read

Computed by āagman
Derived from 10 years and 14 quarters of filings. Not reported by the company.
As of 15 Oct 2026
How we compute these
Piotroski F-Score
4
/ 9
4 of 9 F-score tests passed
Graham Number
₹262
√(22.5 × EPS × book value per share)
ROIC
10.6%
vs 11.2% sector median
Cash flow to profit
1.29
CFO / PAT
Above 1.0 = operating cash flow exceeded reported profit
Margin change
−195
bps OPM YoY
Operating margin vs the same quarter last year
Sustainable growth
14.8%
ROE × earnings retention ratio
ROE stability
1.4
pp σ
Standard deviation of ROE across periods. Lower = more stable
Holder deltas
QoQ
pp
Prom −0.01FII −0.69DII +2.13
Latest quarter vs the previous one
Cash-accrual divergence
−3.0%
of assets
Low = accruals track cash flow
Strengths
+Price trades above its 200-day moving average (1.0x)
Watch-outs
−Borrowings are up 621.2% since FY2016 (165 to 1190)

Peer comparison

Peers
NameP/EMar Cap ₹ CrROCE %ROE %

Quarterly results

Consolidated basis (as filed) · ₹ Cr · 13 quarters
As of 30 Jun 2026
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales7808448368098619579439311,0311,0991,1211,1591,304
Expenses5956316206296757287067077848689049151,017
Operating Profit184213216179186228238225247231217244287
OPM %23.6%25.2%25.8%22.1%21.6%23.8%25.2%24.2%24.0%21.0%19.4%21.1%22.0%
Other Income15211827221816−272036−153722
Interest18201818181616151417222727
Depreciation40434445474948494550616769
Profit before tax141171172143144181189133208200120187213
Net Profit10212512412710613114310115915895142157
EPS (₹)3.804.664.614.743.964.875.323.785.925.893.545.365.90

Profit & Loss

As of 30 Jun 2026
Consolidated · ₹ Cr · 10 years + TTM
Mar 2016Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales1,3821,3431,4561,5001,4472,1672,7103,2753,6924,4104,683
Expenses1,0811,2181,2831,3091,2501,7092,0732,4662,8063,4803,705
Operating Profit301125172192197458637809886930979
OPM %21.8%9.3%11.8%12.8%13.6%21.1%23.5%24.7%24.0%21.1%20.9%
Other Income4549504431394975299880
Interest1428385773868684749092
Depreciation7086102115123130150173194223246
Profit before tax26260836432281449627647715720
Net Profit17033513629196326478481554552
EPS (₹)35.106.7810.447.365.817.7512.1617.8117.9220.7020.69

Balance Sheet

As of 30 Jun 2026
Consolidated · ₹ Cr
Mar 2016Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Jun 2026
Equity Capital48484949505154545454—
Reserves9761,1361,2461,3001,3331,5652,3752,8523,3333,908—
Borrowings1654567879299311,1091,1228027181,190—
Other Liabilities295343347388380421547572662753—
Total Liabilities1,4851,9842,4302,6662,6943,1464,0974,2804,7665,905—
Fixed Assets9141,0941,1941,7031,6161,7762,0502,2362,5143,795—
CWIP12317666382464439327388533132—
Investments0000000033—
Other Assets5595735705816159301,7201,6561,7161,975—
Total Assets1,4851,9842,4302,6662,6943,1464,0974,2804,7665,905—

Cash Flows

As of 31 Mar 2026
Consolidated · ₹ Cr
Mar 2016Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity22863166175242311645612624714
Cash from Investing Activity−241−69−249−87−239−421−342−441−721−1,089
Cash from Financing Activity−7997−1−81160346−514−97272
Net Cash Flow−2031487−7850648−343−194−103

Ratios

As of 31 Mar 2026
10 periods
Mar 2016Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %——6.06.05.015.017.020.020.017.0
ROE %—————————15.2
EPS (₹)35.106.7810.447.365.817.7512.1617.8117.9220.70
Book Value (₹)—————————147.0
Face Value (₹)—————————2
P/E—————————61.6
Div Yield %—————————0.04
NPM %11.92.43.42.32.08.911.814.312.912.3
OPM %22.09.012.013.014.021.024.025.024.021.0
D/E0.160.390.610.690.670.690.460.280.210.30
P/B—————————8.9

Growth

As of 11 Oct 2026
Compounded sales growth
10 years+12.0%
5 years+25.0%
3 years+18.0%
TTM+21.0%
Compounded profit growth
10 years+13.0%
5 years+81.0%
3 years+19.0%
TTM+0.0%
Stock price CAGR
3 years+20.0%
Last year−3.0%
Return on equity
5 years16.0%
3 years16.0%
Last year15.0%

Shareholding pattern

As of 30 Sep 2024
Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024
Promoters33.08%33.08%33.04%33.03%33.01%33.00%
FIIs9.89%9.89%12.10%11.76%10.15%9.46%
DIIs12.34%12.34%10.25%11.93%14.76%16.89%
Government——————
Public44.67%44.67%44.60%43.28%42.01%40.55%
No. of shareholders1,07,1201,07,1201,66,2531,54,6881,47,3901,40,531
Change since Jun 2023 (pp)
Promoters −0.08FIIs −0.43DIIs +4.55Public −4.12

Documents

As of 11 Oct 2026
Announcements
Intimation Under Regulation 30 Of SEBI (Listing Obligation & Disclosure Requirements) Regulation 2015 - ESG Rating Assigned By Crisil ESG Ratings & Analytics Limited.Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseIntimation Under Regulation 30 Of The Listing Regulations.Closure of Trading WindowAnnouncement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Annual reports
Annual Report 2026Annual Report 2025Annual Report 2024Annual Report 2023
Credit ratings
Rating updateRating updateRating updateRating updateRating update
Concalls
Aug 2026TranscriptAug 2026PPTAug 2026RecordingMay 2026TranscriptMay 2026PPTMay 2026RecordingFeb 2026TranscriptFeb 2026PPTFeb 2026RecordingNov 2025TranscriptNov 2025PPTNov 2025RecordingAug 2025TranscriptAug 2025PPT

Corporate actions

As of 14 Aug 2026
14 Aug 2026DIVIDENDDividend - Re 0.50 Per Share—
22 Aug 2025DIVIDENDDividend - Re 0.50 Per Share—
Fundamentals from a third-party compiler of exchange filings; prices from the exchanges. Not investment advice.© 2026 āagman